What is the GeneFerm Biotechnology Co., Ltd. stock price forecast?

GeneFerm Biotechnology Co., Ltd. is currently trading at $33.75. View real-time AI analysis on Alpha Lenz.

What is GeneFerm Biotechnology Co., Ltd. insider trading activity?

View the latest insider trading data for GeneFerm Biotechnology Co., Ltd. on Alpha Lenz.

What is GeneFerm Biotechnology Co., Ltd.'s P/E ratio?

View GeneFerm Biotechnology Co., Ltd.'s valuation metrics on Alpha Lenz.

GeneFerm Biotechnology Co., Ltd.

TWSE · 1796

NT$33.75-0.20(-0.59%)

Ask about GeneFerm Biotechnology Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“GeneFerm Biotechnology Co., Ltd.'s ROE is 3.6%. Explore profitability and growth together.”

Ask for details →

Company Overview

GeneFerm Biotechnology Co., Ltd. is a biotechnological manufacturing company founded in 1999 and headquartered in Tainan, Taiwan. The company specializes in the development, mass production, and sale of health food products and functional food ingredients, leveraging advanced microbial fermentation technologies. Its portfolio includes products such as nattokinase, red yeast rice, medicinal fungi, probiotics, herbal extracts, marine collagen peptides, and d-glucosamine powder. GeneFerm serves industries ranging from pharmaceuticals to food and beverage by offering toll manufacturing services and custom solutions that emphasize quality, innovation, and international compliance. Through continual investment in research and development, as well as holding numerous patents and certifications, GeneFerm plays a significant role in supporting both the consumer health and nutrition sector and upstream supply chains within the broader biotechnology and food processing landscape.

Websitehttps://www.geneferm.com

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Company Statistics

FY 2025

Profile

N/AMarket Cap

NT$677.10MRevenue

0.00Shares Out

0Employees

Margins

28.18%Gross

17.04%EBITDA

6.80%Operating

5.12%Pre-Tax

4.26%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

2.22%Rev 3Yr

12.95%Rev 5Yr

-23.11%Op Inc 3Yr

20.60%Op Inc 5Yr

-32.41%Net Inc 3Yr

44.83%Net Inc 5Yr

Returns

2.38%ROA

3.60%ROE

3.37%ROIC

Financial Health

NT$280.26MCash & Cash Equivalents

NT$183.74MNet Debt

56.82%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“GeneFerm Biotechnology Co., Ltd.'s ROE is 3.6%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

GeneFerm Biotechnology Co., Ltd. (ticker: 1796) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

The current price is 33.75 with a P/E ratio of -x and P/B of -x.

ROE is 3.60% and operating margin is 6.80%. Annual revenue is $677M.